Ribavirin monotherapy for chronic hepatitis C

Jesper Brok; Lise Lotte Gluud; Christian Gluud

doi:10.1002/14651858.CD005527.pub2

Ribavirin monotherapy for chronic hepatitis C

Jesper Brok
, Lise Lotte Gluud
, Christian Gluud

Copenhagen Trial Unit Rigshospitalet

26 Citationer (Scopus)

Abstract

Hepatitis C is a major cause of liver-related morbidity and mortality. A high proportion of patients never experience symptoms. Peginterferon plus ribavirin is the recommended treatment for chronic hepatitis C. However, ribavirin monotherapy may be considered for some patients.

Originalsprog	Engelsk
Tidsskrift	Cochrane Database of Systematic Reviews
Udgave nummer	4
Sider (fra-til)	CD005527
ISSN	1469-493X
DOI	https://doi.org/10.1002/14651858.CD005527.pub2
Status	Udgivet - 2009

Adgang til dokumentet

10.1002/14651858.CD005527.pub2

Citationsformater

@article{5a18238e2c844d52896fe1d8108c08e6,

title = "Ribavirin monotherapy for chronic hepatitis C",

abstract = "Hepatitis C is a major cause of liver-related morbidity and mortality. A high proportion of patients never experience symptoms. Peginterferon plus ribavirin is the recommended treatment for chronic hepatitis C. However, ribavirin monotherapy may be considered for some patients.",

keywords = "Anemia, Antiviral Agents, Hepatitis C, Chronic, Humans, Interferons, Randomized Controlled Trials as Topic, Ribavirin, Viral Load",

author = "Jesper Brok and Gluud, \{Lise Lotte\} and Christian Gluud",

year = "2009",

doi = "10.1002/14651858.CD005527.pub2",

language = "English",

pages = "CD005527",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "John Wiley and Sons Ltd",

number = "4",

}

TY - JOUR

T1 - Ribavirin monotherapy for chronic hepatitis C

AU - Brok, Jesper

AU - Gluud, Lise Lotte

AU - Gluud, Christian

PY - 2009

Y1 - 2009

N2 - Hepatitis C is a major cause of liver-related morbidity and mortality. A high proportion of patients never experience symptoms. Peginterferon plus ribavirin is the recommended treatment for chronic hepatitis C. However, ribavirin monotherapy may be considered for some patients.

AB - Hepatitis C is a major cause of liver-related morbidity and mortality. A high proportion of patients never experience symptoms. Peginterferon plus ribavirin is the recommended treatment for chronic hepatitis C. However, ribavirin monotherapy may be considered for some patients.

KW - Anemia

KW - Antiviral Agents

KW - Hepatitis C, Chronic

KW - Humans

KW - Interferons

KW - Randomized Controlled Trials as Topic

KW - Ribavirin

KW - Viral Load

U2 - 10.1002/14651858.CD005527.pub2

DO - 10.1002/14651858.CD005527.pub2

M3 - Journal article

C2 - 19821346

SN - 1469-493X

SP - CD005527

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 4

ER -

Ribavirin monotherapy for chronic hepatitis C

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater